Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Lercanidipine 20 mg approved in Europe

March 7, 2003

Ranexa NDA accepted for filing

March 7, 2003

New modulators of vasopressin and/or oxytocin receptors covered by Sanofi-Synthelabo patent

March 7, 2003

Chronic propagermanium may be useful in atherosclerotic vascular disease

March 4, 2003

HANP 1000 agreement reached

March 4, 2003

GSK initiates clinical trials of genomics-derived drug from HGS collaboration

March 4, 2003

AGI-1067 equally effective and safer than probucol after PCI

March 3, 2003

Chymase inhibitor prevents intimal hyperplasia after ballon injury

Feb. 28, 2003

Binding kinetics and cardioprotective effects of sabiporide characterized

Feb. 27, 2003

Enrollment completed in phase III PRIMO-CABG trial of pexelizumab

Feb. 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...